Open AccessExploiting Temozolomide-Induced Hypermutation With Pembrolizumab in a Refractory High-Grade Neuroendocrine Neoplasm: A Proof-of-Concept Case
Author(s) -
Samuel J. Klempner,
Andrew Hendifar,
Kevin Waters,
Nicholas N. Nissen,
Eric Vail,
Richard Tuli,
Alain C. Mita
Publication year - 2020
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.20.00034
Subject(s) - pembrolizumab , temozolomide , somatic hypermutation , refractory (planetary science) , neoplasm , medicine , cancer research , oncology , glioblastoma , biology , antibody , cancer , pathology , immunology , astrobiology , immunotherapy , b cell
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom